Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies - PubMed (original) (raw)

Meta-Analysis

Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies

Wing-Chi G Yeung et al. BMJ. 2011.

Abstract

Objective: To review the association between current enterovirus infection diagnosed with molecular testing and development of autoimmunity or type 1 diabetes.

Design: Systematic review and meta-analysis of observational studies, analysed with random effects models.

Data sources: PubMed (until May 2010) and Embase (until May 2010), no language restrictions, studies in humans only; reference lists of identified articles; and contact with authors. Study eligibility criteria Cohort or case-control studies measuring enterovirus RNA or viral protein in blood, stool, or tissue of patients with pre-diabetes and diabetes, with adequate data to calculate an odds ratio and 95% confidence intervals.

Results: The 24 papers and two abstracts (all case-control studies) that met the eligibility criteria included 4448 participants. Study design varied greatly, with a high level of statistical heterogeneity. The two separate outcomes were diabetes related autoimmunity or type 1 diabetes. Meta-analysis showed a significant association between enterovirus infection and type 1 diabetes related autoimmunity (odds ratio 3.7, 95% confidence interval 2.1 to 6.8; heterogeneity χ(2)/df = 1.3) and clinical type 1 diabetes (9.8, 5.5 to 17.4; χ(2)/df = 3.2).

Conclusions: There is a clinically significant association between enterovirus infection, detected with molecular methods, and autoimmunity/type 1 diabetes. Larger prospective studies would be needed to establish a clear temporal relation between enterovirus infection and the development of autoimmunity and type 1 diabetes.

PubMed Disclaimer

Conflict of interest statement

Competing interests: All authors have completed the Unified Competing Interest form at www.icmje.org/coi\_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous 3 years; no other relationships or activities that could appear to have influenced the submitted work.

Figures

None

Fig 1 Odds ratios for enterovirus positivity in patients with pre-diabetes versus no diabetes

None

Fig 2 Odds ratios for enterovirus positivity in patients with and without diabetes

Comment in

Similar articles

Cited by

References

    1. Hober D, Sauter P. Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host. Nat Rev Endocrinol 2010;6:279-89. - PubMed
    1. Diamond PG. Incidence and trends of childhood type 1 diabetes worldwide 1990-1999. Diabet Med 2006;23:857-66. - PubMed
    1. EURODIAB. Variation and trends in incidence of childhood diabetes in Europe. Lancet 2000;355:873-6. - PubMed
    1. Patterson C, Dahlquist G, Gyürüs E, Green A, Soltész G. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 2009;373:2027-33. - PubMed
    1. Chong J, Craig M, Cameron F, Clarke C, Rodda C, Donath S, et al. Marked increase in type 1 diabetes mellitus incidence in children aged 0-14 yrs in Victoria, Australia, from 1999 to 2002. Pediatr Diabetes 2007;8:67-73. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources